SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001069530-17-000024
Filing Date
2017-04-26
Accepted
2017-04-25 19:18:22
Documents
42
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptie-20170331x10q.htm 10-Q 1224057
2 EX-31.1 ptie-20170331xex31_1.htm EX-31.1 18623
3 EX-32.1 ptie-20170331xex32_1.htm EX-32.1 9222
  Complete submission text file 0001069530-17-000024.txt   4115320

Data Files

Seq Description Document Type Size
4 EX-101.INS ptie-20170331.xml EX-101.INS 980885
5 EX-101.SCH ptie-20170331.xsd EX-101.SCH 22683
6 EX-101.CAL ptie-20170331_cal.xml EX-101.CAL 34475
7 EX-101.DEF ptie-20170331_def.xml EX-101.DEF 63847
8 EX-101.LAB ptie-20170331_lab.xml EX-101.LAB 172355
9 EX-101.PRE ptie-20170331_pre.xml EX-101.PRE 146217
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
PAIN THERAPEUTICS INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 17782216
SIC: 2834 Pharmaceutical Preparations